Seaweed extract shown to relieve prostate symptoms

Contributed by: PR Newswire

Images

PR Newswire associated0

PR Newswire associated1

Tags

Marinova-Clinic-Trial

More Like This

New Clinical Results Highlight the Skincare Potential of Baltic Bladderwrack in Finnish Innovation by Saaren Taika

PR Newswire associated0

New Study Finds Pycnogenol® Alleviates Cellulite in Women

PR Newswire associated0

Alphyn to Present Poster on Zabalafin Hydrogel Clinical Results at European Academy of Dermatology and Venereology Congress 2024

PR Newswire associated0

Amorepacific Research Confirms Potential of Microalgal-Derived PDRNs in Skin Regeneration and Wound Healing

In 2008, GN Corp initiated research with NCRM, Chennai, Tamil Nadu, India on restoring corneal blindness using buccal tissue epithelial cells. An out of the box idea of Dr. Suryaprakash, Urologist from Hyderabad, India in 2012 to apply buccal (oral) mucosal cells to repair stricture-inflicted male urethra, led to a clinical study, which he presented in NCRM NICHE 2017 in Tokyo, kickstarting a collaboration with Dr. Akio Horiguchi, National Defence Medical College, Japan, as they met in EAU in 2018 (Top right picture). Upon confirming successful cell engraftment in urethral stricture pre-clinical models taking help from the Dept. of Medical Engineering of NDMC between 2018~2023, (Bottom, right picture), now in 2025, clinical application has been initiated in Edogawa Hospital, Tokyo. Main picture: BEES-HAUS team after the first clinical transplant in Edogawa Hospital, Tokyo; Dr.Horiguchi (Centre) with Dr.Shojiro Katoh (President, Edogawa Hospital) standing left to him.

Cell therapy for male urethral stricture: BEES-HAUS clinical application in Edogawa Hospital Japan, reports Dr. Akio Horiguchi in IMORU.

PR Newswire associated0

Clinical Trial Shows Pycnogenol® Significantly Relieves Lipedema Symptoms and Improves Quality of Life in Women

PR Newswire associated0

Alphyn Receives Notice of Claims Allowance for U.S. Patent Covering Zabalafin Hydrogel

Tsuno Group successfully developed and applied for a patent for a stable formulation with a high dosage of FERULIC ACID, a rare natural plant-derived ingredient having the function of absorbing UV.